MediPines AGM100®
Respiratory Monitoring System
Improve Patient Outcomes
Drive Healthcare Efficiency
Clarity in Clinical Decision Making
MediPines AGM100®
A Portable Two-Minute Test for Respiratory Impairment Detection
Prepare for COVID-19 Surge
Rapidly Triage and Manage Respiratory Patients
MediPines AGM100 is a portable respiratory monitor designed to provide non-invasive detection of respiratory status and pulmonary gas exchange. The MediPines AGM100 is FDA cleared for use in any qualified healthcare facility and received emergency authorization by Health Canada for COVID-19.
How Does a Non-Invasive PaO2 Compare to an Arterial Blood Gas PaO2?
What Level of Gas Exchange Impairment Does Respiratory Monitoring Detect in Patients with Lung Disease?
Testimonials
“We are measuring patients in the emergency room. It’s a form of triage, for what kind of care we are going to provide in the emergency room and possibly as an indicator for whether or not these patients have silent hypoxemia and whether or not these patients should be admitted to the hospital or not.”
Ron Pasewald, RRT, Past President of Wisconsin Society for Respiratory Care
“Quite frankly, over 15% of our surgical patients have COPD and many more don’t know they have respiratory issues. That is why we are using the MediPines AGM100® here to fast screen these patients, pre-surgery…”
Leading Academic M.D., Medical Center Director
So, what makes the MediPines Gas Exchange Monitor interesting?
Simply put, it’s new. The Gas Exchange Monitor is the first medical device to integrate a “comprehensive set” of respiratory parameters and indicators drawn from a patient’s breath in a noninvasive test. What’s key is the word “noninvasive.”
MedTech Boston
“The AGM100 is so easy to use and portable. You get the data in minutes, instead of hours so I can separate ‘respiratory’ from ‘non-respiratory’ patients. It also worked seamlessly when I took it to remote rural areas where we did not have access to labs nearby…the next hospital is 160 miles away and the only way to transport patients to a hospital was via helicopter.”
Emergency Physician
Schedule an in-person or video conference demonstration of the MediPines Respiratory Monitoring System.
MediPines products are produced in our FDA-registered, MDSAP ISO13485:2016 certified manufacturing facility in California.
MediPines News
MediPines AGM100® Gas Exchange Measurements Validated Against ABGs (Arterial Blood Gases)
Study Published in CHEST Validates MediPines AGM100® Non-invasive Pulmonary Gas Exchange Measurements with Arterial Blood Gases Under Hypoxic Conditions ORANGE COUNTY, Calif., May 12, 2020 /PRNewswire/ — A collaborative of international researchers, led by Dr. Phil Ainslie of the University of British Colombia (UBC), published the results of extensive research on the reliability of the MediPines AGM100®, a non-invasive […]
MediPines AGM100 Authorized for COVID-19 Emergency by Health Canada
NEWS PROVIDED BYMediPines Apr 28, 2020, 13:16 ET ORANGE COUNTY, Calif., April 28, 2020 /PRNewswire/ — Health Canada, the regulatory agency governing medical devices in Canada, has authorized the emergency importation and sale of the MediPines AGM100®, a pulmonary gas exchange monitor to help combat the COVID-19 pandemic in Canada. The MediPines AGM100® is a non-invasive, portable respiratory medical device used […]
MediPines Obtains International MDSAP ISO 13485 Medical Device Certification
ORANGE COUNTY, Calif., April 9, 2020 /PRNewswire/ — MediPines Corporation announces that it received the Medical Device Single Audit Program certification, MDSAP ISO 13485:2016 certification for Medical Device and Quality Management Systems. MediPines Corporation is the manufacturer of portable respiratory monitoring devices designed to provide real-time, clinically actionable data. ISO 13485:2016 is an internationally recognized quality standard developed to […]
COVID-19 Patients Being Triaged and Assessed Using 2 Minute Breath-Based Gas Test
ORANGE COUNTY, Calif., April 6, 2020 /PRNewswire/ — Innovative hospitals across North America are responding to the COVID-19 pandemic and the upsurge of patients with a revolutionary breath-based gas test to support faster patient assessment, triage, and treatment decisions. The medical device uses advanced technology and proven medical methods to measure a patient’s degree of respiratory impairment. The new […]
MediPines Releases COVID-19 Statement of Guidance for Pulmonary Gas Exchange Monitoring
NEWS PROVIDED BY MediPines ORANGE COUNTY, Calif., March 12, 2020 /PRNewswire/ — MediPines Corporation, in keeping with their mission of advancing respiratory medicine, has released a statement of guidance on the use of the MediPines Gas Exchange Monitor (AGM100®) in the monitoring of patients that have symptoms of suspected COVID-19 or other respiratory infections. The guidance was developed in collaboration […]
MediPines a Featured Innovator at Emerging Medtech Summit 2020
ORANGE COUNTY, Calif., Jan. 29, 2020 /PRNewswire/ — MediPines Corporation announces its selection as a top medtech innovator at the Emerging Medtech Summit 2020. The event takes place February 18-20th, 2020 at the Ritz Carlton Laguna Niguel and features top strategists, investors, and innovators. MediPines CEO and founder, Steve Lee, will address the summit on February 18th in the afternoon and is meeting […]
MediPines Oxistimulator® Demonstrates Reduced Oxygen Desaturations in Postoperative Patients
Positive Clinical Trial Results Published https://www.prnewswire.com/news-releases/medipines-oxistimulator-demonstrates-reduced-oxygen-desaturations-in-postoperative-patients-300960352.html ORANGE COUNTY, Calif., Nov. 19, 2019 /PRNewswire/ — MediPines announces the publication of the positive clinical study results on Oxistimulator®, a breakthrough technology designed to reduce postoperative hypoxemia in patients at-risk for Obstructive Sleep Apnea (OSA). The study demonstrated that the Oxistimulator technology decreases the duration and magnitude of hypoxemia, often referred to as oxygen […]
MediPines AGM100® Launched for Perioperative Screening at 2 Leading Medical Centers
NEWS PROVIDED BY MediPines Sep 10, 2019, 13:33 ET ORANGE COUNTY, Calif., Sept. 10, 2019 /PRNewswire/ — MediPines Corporation in Orange County, CA announces the launch of the MediPines Gas Exchange Monitor (AGM100) in two major East and West Coast hospitals. The AGM100 is being deployed to support screening and stratification of surgical patients for risks in perioperative settings. Postoperative pulmonary complications (PPC) […]
Respiratory Physiology – John B. West Lecture Series Launched by UC San Diego School of Medicine and MediPines
ORANGE COUNTY, Calif., July 17, 2019 /PRNewswire/ — UC San Diego School of Medicine and MediPines Corporation, a medical device company based in Orange County, California announce the establishment of the “John B. West Distinguished Lecture Series in Respiratory Physiology and Pathophysiology” to help advance the field of respiratory medicine. The inaugural lecture will feature noted scholar, Joe G. N. Garcia M.D., […]
FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study
Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida PR Newswire ORANGE COUNTY, Calif., April 12, 2019 /PRNewswire/ — Novel physiologic results on world elite freedivers’ using the non-invasive MediPines Gas Exchange Monitor (https://bit.ly/2YVAG1M) were presented at the Experimental Biology 2019 conference. Dr. Philip Ainslie, Co-Director of the Centre for Heart, Lung […]
MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor
ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the MediPines Gas Exchange Monitor. The MediPines Gas Exchange Monitor provides clinicians with real-time pulmonary parameters and insights to support rapid triage and treatment decisions for respiratory conditions. The MediPines […]
Positive Clinical Results Presented at American Thoracic Society (ATS) Conference in San Diego, California.
A group of physicians and researchers presented initial findings at recently held ATS event in San Diego, California where they presented clinical study results, clinical implications and ongoing research areas. Additional opportunities were debated with other medical researchers and broader medical community. American Thoracic Society (ATS) Background American Thoracic Society (ATS) is a nonprofit organization […]
Clinical Trial Results Published in CHEST Demonstrate Feasibility for Non-Invasive Gas Exchange Concept.
Non-invasive way to measure the degree of impaired gas exchange has been proposed and published with supporting study results. CHEST is a peer-reviewed medical journal covering chest diseases and related issues including pulmonology, cardiology, breathing, airway diseases and emergency medicine. The journal was established in 1935. For more on CHEST, https://journal.chestnet.org/
MediPines Acquires Oxistimulator Technology from Mayo Clinic
https://www.prnewswire.com/news-releases/medipines-acquires-oxistimulator-technology-from-mayo-clinic-300547532.html ORANGE COUNTY, California, Nov. 1, 2017 — MediPines announced today that it has acquired medical technology designed to reduce respiratory complications in post-surgical patients by preventing oxygen desaturations (i.e. low oxygen levels).
MediPines Announces Research Collaboration with UC San Diego Medical Team to Monitor Pulmonary Gas Exchange Non-Invasively
ORANGE COUNTY, California, May 10, 2017 — MediPines announced today that it has been partnering with the University of California San Diego (UC San Diego) to advance development of a novel, non-invasive medical device designed to monitor pulmonary gas exchange (i.e. lung function).
